SCHEMBL8106324

SCHEMBL8106324

CCc1c(OCCCCCCBr)c(C(=O)O)c(CC)c(OCCCCCCBr)c1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
PLA2G4B P0C869 5/20 0.40
THRA P10827 3/20 0.39
THRB P10828 3/20 0.39
RARB P10826 3/20 0.38
HTT P42858 1/20 0.38
PLA2G4A P47712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8100381 1.00 PLA2G2A (0.41) PLA2G2ATP53TSHRPLA2G4BTHRA
SCHEMBL668868 0.87 PLA2G2A (0.50) PLA2G2ATP53TSHRPLA2G4BTHRA
SCHEMBL17186650 0.85 THRA (0.40) PLA2G2ATP53TSHRPLA2G4BTHRA
SCHEMBL7759784 0.84 ALDH1A1 (0.44) PLA2G2ATP53TSHRPLA2G4BTHRA
SCHEMBL17186600 0.84 PLA2G2A (0.37) PLA2G2ATP53TSHRPLA2G4BTHRA
SCHEMBL7754588 0.84 ALDH1A1 (0.44) PLA2G2ATP53TSHRPLA2G4BTHRA
SCHEMBL8100384 0.79 PTPN11 (0.37) PLA2G2ATSHR
SCHEMBL8106327 0.79 PTPN11 (0.37) PLA2G2ATSHR
SCHEMBL5587043 0.74 PLA2G2A (0.44) PLA2G2ATP53TSHRPLA2G4BTHRA
SCHEMBL5589712 0.74 PLA2G2A (0.44) PLA2G2ATP53TSHRPLA2G4BTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10923662-B2 Fluoroalkylfluorene derivatives LOMOX LIMITED (GB) 2021-02-16 US disclosed
EP-3131898-B1 FLUOROALKYLFLUORENE DERIVATIVES LOMOX LTD (GB) 2020-03-18 EP disclosed
EP-3362434-B1 CROSS-LINKABLE CHARGE TRANSPORT MATERIALS LOMOX LTD (GB) 2019-08-28 EP disclosed
US-20180309064-A1 CROSS-LINKABLE CHARGE TRANSPORT MATERIALS LOMOX LIMITED (GB) 2018-10-25 US disclosed
US-10084137-B2 Fluoroalkylfluorene derivatives LOMOX LIMITED (GB) 2018-09-25 US disclosed
US-20180261771-A1 FLUOROALKYLFLUORENE DERIVATIVES LOMOX LIMITED (GB) 2018-09-13 US disclosed
EP-3362434-A1 CROSS-LINKABLE CHARGE TRANSPORT MATERIALS Lomox Limited (GB) 2018-08-22 EP disclosed
WO-2017064490-A1 CROSS-LINKABLE CHARGE TRANSPORT MATERIALS LOMOX LIMITED (GB) 2017-04-20 WO disclosed
EP-3131898-A1 FLUOROALKYLFLUORENE DERIVATIVES Lomox Limited (GB) 2017-02-22 EP disclosed
US-20170033290-A1 FLUOROALKYLFLUORENE DERIVATIVES LOMOX LIMITED (GB) 2017-02-02 US disclosed
WO-2015159098-A1 FLUOROALKYLFLUORENE DERIVATIVES LOMOX LIMITED (GB) 2015-10-22 WO disclosed
US-6031015-A POLYMERIZABLE POLYESTER OF 1-10 REPEATING UNITS BEING MODIFIED ON BOTH ENDS BY A HYDROXYALKYL (METH)ACRYLATE; SHRINKAGE INHIBITION; LOW VISCOSITY; MECHANICAL STRENGTH; CAN INCLUDE MORE FILLER THAN USUAL IVOCLAR AG (LI) 2000-02-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10084137-B2 Fluoroalkylfluorene derivatives FLNB, AFF2, EFHD2 PLA2G2A 1082/4885TP53 3414/4885TSHR 3720/4885
US-20170033290-A1 FLUOROALKYLFLUORENE DERIVATIVES FLNB, AFF2, EFHD2 PLA2G2A 1082/4885TP53 3414/4885TSHR 3720/4885
US-20180309064-A1 CROSS-LINKABLE CHARGE TRANSPORT MATERIALS CHRM1, CHRM2, SLC43A1 PLA2G2A 621/4885TP53 4241/4885TSHR 1917/4885
US-10923662-B2 Fluoroalkylfluorene derivatives FLNB, AFF2, EFHD2 PLA2G2A 1082/4885TP53 3414/4885TSHR 3720/4885
US-20180261771-A1 FLUOROALKYLFLUORENE DERIVATIVES FLNB, AFF2, EFHD2 PLA2G2A 1082/4885TP53 3414/4885TSHR 3720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.